(Q44347605)

2 December 2017

Eliciting preferences for prioritizing treatment of rare diseases: the role of opportunity costs and framing effects (English)

1 reference

2 December 2017

1 reference

1 reference

Arna S Desser

1

1 reference

PubMed ID

24114738

2 December 2017

Jan Abel Olsen

series ordinal

2

1 reference

PubMed ID

24114738

2 December 2017

Sverre Grepperud

series ordinal

3

1 reference

2 December 2017

1 November 2013

1 reference

2 December 2017

1 reference

2 December 2017

31

1 reference

2 December 2017

11

1 reference

2 December 2017

1051-1061

1 reference

https://scigraph.springernature.com/pub.10.1007/s40273-013-0093-y

2 December 2017

0 references

cites work

The framing of decisions and the psychology of choice

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

Threats to the estimation of benefit: are preference elicitation methods accurate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

On the elicitation of preferences for alternative therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

Orphan drugs and the NHS: should we value rarity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

Drugs for exceptionally rare diseases: do they deserve special status for funding?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

Preferences for the normative basis of health care priority setting: some evidence from two countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

EuroQol--a new facility for the measurement of health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

The Default Effect in End-of-Life Medical Treatment Preferences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40273-013-0093-Y

Assessing the economic challenges posed by orphan drugs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24114738

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S40273-013-0093-Y

1 reference

2 December 2017

1 reference

PubMed ID

24114738